# Baslon OS — Timeline

How Baslon OS reached its current state, reconstructed from Git history and the repository's own documentation. Read this with [`milestones.md`](milestones.md) for the stage map and [`decision-log.md`](decision-log.md) for the reasoning.

The project's first commit is dated **13 September 2026**; the current endpoint is **23 September 2026**. Every date below comes from Git.

---

## 13 September 2026 — Product foundations

### Problem / objective

Build the first working slice of a strategic decision-support system for established service businesses: something that takes imperfect business information and turns it, step by step, into structured evidence, then identified gaps and contradictions, then a diagnosis a human can approve and audit.

### Decision / work

The founding brief set the governing principle that still constrains every part of the system:

> **AI proposes. Software validates and calculates. Humans make material strategic decisions.**

It also set the negative definition, which matters as much: Baslon OS is not a generic AI business adviser, chatbot, CRM, task manager or report generator.

The repository was initialised with its operating instructions and that brief (`f1a2703`, `679bc97`).

### Result

A product whose architecture is organised around one separation: **canonical business truth** (what the business has actually told us and a human has authorised) versus **analytical interpretation** (what a model infers from it). The two are never allowed to merge silently.

### Why it mattered

Every later design argument — precision, provenance, gaps, diagnosis, headlines — resolves back to that separation. It is the reason the system has human review checkpoints rather than an "approve all" button.

### Relevant records

- Build brief: [`briefs/001-phase-1-strategic-diagnosis.md`](../../briefs/001-phase-1-strategic-diagnosis.md)
- Operating rules: [`AGENTS.md`](../../AGENTS.md), [`docs/domain-invariants.md`](../domain-invariants.md), [`docs/ai-boundaries.md`](../ai-boundaries.md)
- Commits `f1a2703`, `679bc97`

---

## 13 September 2026 — Milestone 1: the domain foundation

### Problem / objective

Before any AI work, the system needed a domain model that could hold evidence honestly: what is claimed, what supports it, what is measured, and what state the business is in.

### Decision / work

Implemented the foundation (`7d94fec`, `0c3fb6c`): Business, a workflow state model, Claims, Evidence, Metrics, Claim–Evidence relationships, immutable Business State Snapshots, provenance on records, and analysis runs as the unit of AI execution.

### Result

A schema where strategically important concepts are explicit domain entities rather than fields inside opaque JSON, and where a Snapshot is a frozen, addressable view of canonical state.

### Why it mattered

Immutable Snapshots later made reproducible analysis possible: a diagnosis reads one exact snapshot, and the same snapshot can be re-read afterwards to verify what the analysis saw.

### Relevant records

- [`docs/milestone-1-foundation.md`](../milestone-1-foundation.md)
- Commits `7d94fec`, `0c3fb6c`

---

## 13–15 September 2026 — Milestone 2: extraction, then human review

### Problem / objective

Business owners supply messy prose, not structured records. The system needed to read that prose — but without letting a model write canonical truth.

### Decision / work

Milestone 2A added Evidence Extraction through an injectable model behind a versioned prompt, with strict schema validation of untrusted output (`b22a798`). Milestone 2B then added the human Evidence Review step (`1b310ab`) and the workflow was stabilised (`4f82448`).

Model output became a **proposal**. A human decides Accept, Correct, Reject or Unresolved, and only that decision creates canonical Claims, Evidence and Metrics. Model-written provenance stays as read-only audit detail and never becomes the canonical value.

### Result

A pipeline where AI does the language work and a person authorises the facts. The user experience was redesigned around this review flow (`8acc709`), and Business archive/restore (`0ab626c`) and a guarded permanent-delete path (`edb60e9`) followed.

### Why it mattered

This is the first concrete expression of the founding principle, and the pattern every later AI feature copies: propose → validate → human decision → persisted state.

### Relevant records

- [`docs/milestone-2-evidence-engine.md`](../milestone-2-evidence-engine.md)
- Commits `b22a798`, `1b310ab`, `4f82448`, `8acc709`, `0ab626c`, `edb60e9`

---

## 15–17 September 2026 — Milestone 3: continuous evidence and coherence

### Problem / objective

A business is not described once. New information arrives, and the system had to absorb it repeatedly without losing history or quietly rewriting what was already reviewed.

### Decision / work

Milestone 3A built the continuous-evidence foundation (`0009530`) and 3B made Add Information repeatable (`cbdff69`). Milestone 3C introduced **Evidence Coherence** (`3c77a48`): an analysis that reads one immutable snapshot and reports material contradictions and important evidence gaps.

Coherence findings are deliberately analytical only. They are bound to their analysis run and snapshot, and they never update canonical evidence state.

### Result

New information produces a new reviewed state and a newer Snapshot; earlier Snapshots stay immutable. Evidence quality became visible as its own surface rather than an implicit property.

### Why it mattered

It established that the system can say "we do not know this" as a first-class result — the ancestor of the gap handling that Phase 1 depends on.

### Relevant records

- [`docs/milestone-3c-evidence-coherence.md`](../milestone-3c-evidence-coherence.md)
- Commits `0009530`, `cbdff69`, `3c77a48`

---

## 17–18 September 2026 — Milestone 3D: hardening before diagnosis

### Problem / objective

Before building diagnosis, the existing workflow needed to be safe under failure and concurrency.

### Decision / work

Analysis isolation by module, recovery for abandoned runs, archive-safe strategic writes (`aebd25a`), PostgreSQL test-database safety (`60c8920`), and the initial-intake guard that stops a new intake invalidating an open review (`0d36f05`, merged as PR #1, `93e03e3`). The consolidated findings register was created at this point (`44e2bc1`) and has tracked open work since.

### Result

Milestone 3D merged at `8602b98`; the register became the authoritative tracker for unresolved findings.

### Why it mattered

Diagnosis writes strategic state. Hardening the evidence workflow first meant the diagnosis work could assume a stable base.

### Relevant records

- [`docs/milestone-3d-pre-diagnosis-hardening.md`](../milestone-3d-pre-diagnosis-hardening.md), [`docs/milestone-3d-architectural-review-handoff.md`](../milestone-3d-architectural-review-handoff.md)
- [Findings register](../baslon-os-consolidated-code-review-findings-register.md)
- Commits `8602b98`, `aebd25a`, `60c8920`; PR #1 (`93e03e3`)

---

## 18 September 2026 — Milestone 4A: the gap-resolution checkpoint

### Problem / objective

When coherence reports gaps, what should happen? Blocking forever is useless; ignoring them silently is dishonest.

### Decision / work

`GAP_RESOLUTION_REQUIRED` became an explicit **human** checkpoint (PR #2, `57bddec`). A person can add information to close a gap, or explicitly continue with the gaps still open, which moves the workflow to `PHASE1_READY`.

### Result

A controlled, audited entry into Phase 1. Milestone 4A itself added no diagnosis engine, persistence or migration.

### Why it mattered

It made "we are proceeding while knowingly ignorant of these things" a recorded decision rather than an accident — which is exactly how the Baslon rebuild later entered Phase 1.

### Relevant records

- [`docs/milestone-4a-gap-resolution-phase1-entry.md`](../milestone-4a-gap-resolution-phase1-entry.md)
- PR #2 (`57bddec`)

---

## 19 September 2026 — M4-02A: numeric precision

### Problem / objective

A founder says "about £80,000". Stored as `80000`, that becomes indistinguishable from an exact figure — and any later calculation inherits a precision the business never claimed.

### Decision / work

New canonical Evidence and Metrics carry explicit precision: `exact`, `approximate`, `estimate`, `range` (both bounds kept) and `unspecified`. Ranges are never collapsed to a midpoint. Records created before precision existed read as **`unspecified`**, never as `exact`, and were **not retrofitted** — correcting them would need new human-authorised evidence.

Migration `0006_numeric_precision` was applied to `baslon_os_test` and, with Product Owner approval on 19 September 2026, to live `baslon_os`; all 45 Evidence and 18 Metric rows and all six snapshots were unchanged by it (PR #3, `bba1d08`; implementation `4260071`).

### Result

Uncertainty survives the journey from prose to database to analysis.

### Why it mattered

It is the clearest case of the system refusing to manufacture confidence it does not have — and the reason Phase 1 calculations can be labelled "approximate" honestly.

Live-model validation (H4) followed on 19 September: seven runs against the configured model using fictional input only, no rows created, precision classified correctly each time. One run was rejected, as designed, when the model turned "five-day" into `5` — recorded as backlog **B-31** rather than patched away.

### Relevant records

- Decision: [`docs/baslon-os-m4-02-numeric-precision-architecture-decision.md`](../baslon-os-m4-02-numeric-precision-architecture-decision.md)
- Implementation: [`docs/milestone-4-m4-02a-numeric-precision.md`](../milestone-4-m4-02a-numeric-precision.md)
- Validation: [`docs/m4-02a-h4-live-model-validation.md`](../m4-02a-h4-live-model-validation.md), [`docs/m4-02a-completion-report.md`](../m4-02a-completion-report.md)
- PRs #3 (`bba1d08`), #4 (`94a887e`), #5 (`7997f50`)

---

## 20 September 2026 — M4-11: if Accept will write it, show it

### Problem / objective

A rebuild of the Baslon Digital Business was under way when a material defect surfaced: **Accept was committing qualifier values the reviewer had never been shown**.

### Decision / work

M4-11 and N-1 rebuilt the review card so it displays the complete canonical object that Accept will persist, made evidence type, source notes and Metric dimensions correctable, and moved provenance ownership from the model to the application (PR #6, `13f5df1`; implementation `c7e0b6d`). New records carry `reviewCardVersion = "m4_11_v1"`; older reviewed records show a read-time warning and **no data was changed**.

The in-progress rebuild (Business `9aec14e1-…`, "Baslon Digital — Rebuild 2026") was **paused, not repaired**. It holds Snapshot 1 only and is kept as history.

### Result

The review surface became trustworthy, and the rebuild restarted cleanly in a fresh Business under the new review card.

### Why it mattered

This is the project's clearest example of stopping rather than papering over a problem: the earlier rebuild was superseded openly instead of being silently fixed.

M4-10 followed on 20 September (PR #8, `fddca0b`), narrowing how far one approximation cue carries — it governs a later measurement in the same coordinated phrase ("roughly a three-day, 30-hour working week") and nothing wider.

### Relevant records

- [`docs/milestone-4-m4-11-review-completeness-provenance.md`](../milestone-4-m4-11-review-completeness-provenance.md), [`docs/m4-11-architectural-analysis.md`](../m4-11-architectural-analysis.md)
- PRs #6 (`13f5df1`), #7 (`d0df5a7`), #8 (`fddca0b`)

---

## 21 September 2026 — M4-12: handles instead of UUIDs

### Problem / objective

Evidence Coherence asked the model to cite canonical records by UUID. Models corrupt long identifiers. Two coherence runs on the Baslon rebuild failed for exactly that reason — on Snapshot 3 (`8c3f1af5-…`) and again on Snapshot 4 (`9883e5cb-…`), the second time on the same Evidence.

### Decision / work

Snapshot-local reference handles replaced raw UUIDs in the coherence contract: the model cites `C001`, `E014`, `M003` and the application resolves them to canonical rows (PR #9, `d370d7d`; verification PRs #10, #11).

### Result

The approved coherence run on Snapshot 4 (`bcc6fd6c-…`) succeeded under `evidence_coherence_input_v3` / `evidence_coherence_v4`, reporting **0 contradictions and 6 validated gaps (4 High, 2 Medium)**.

### Why it mattered

The failures were kept in the record, and they directly shaped the design that Phase 1 Diagnosis later inherited — diagnosis cites `C`, `E`, `M`, `G` and `D` handles for the same reason.

### Relevant records

- [`docs/baslon-os-m4-12-evidence-coherence-reference-handles-architecture-decision.md`](../baslon-os-m4-12-evidence-coherence-reference-handles-architecture-decision.md)
- PRs #9 (`d370d7d`), #10 (`6b48a14`), #11 (`dc1d78a`)

---

## 15–21 September 2026 — The controlled Baslon Digital rebuild

### Problem / objective

Baslon Digital is Business #001 and the proving ground. An earlier Business had been contaminated with fictional development data, and a later rebuild was superseded by M4-11. A clean, real run of the whole evidence pipeline was needed.

### Decision / work

Three Businesses exist in the record, and the history keeps all three:

| Business | State | Why |
|---|---|---|
| `68bb7e68-…` | **archived, read-only** | contaminated with fictional development data; preserved as an audit trail, never to be restored or copied from |
| `9aec14e1-…` ("Rebuild 2026") | **superseded** | paused at Snapshot 1 when M4-11 proved the review card incomplete |
| `a658df7e-…` ("Rebuild 2026 v2") | **current** | the clean rebuild, sources S1–S4 processed through human review |

The active original Baslon Digital Business (`74230122-…`) remains untouched at `GAP_RESOLUTION_REQUIRED`; the rebuild was deliberately run in separate Businesses rather than on it.

### Result

**Snapshot 4** `da6e9a8e-1ae0-4436-ab67-429a7d33197b`, fingerprint `bd0e75c5c0c8662dba0edb60b35d5e3b`: **39 Claims, 59 Evidence, 18 Metrics, 54 Claim–Evidence relationships**.

Several deviations were found, **accepted and left unrepaired** rather than quietly corrected: five S3 Evidence records carry inferred period boundaries, and S4 contains a garbled `claim_1`, a duplicate clean `claim_2` and a non-standard `metric_1` dimension. They remain in the record as they were reviewed.

### Why it mattered

It is the first end-to-end proof that the evidence pipeline works on real business information, and the snapshot every later Phase 1 artifact is bound to.

### Relevant records

- [`docs/current-status.md`](../current-status.md) — the authoritative per-Business detail

---

## 21 September 2026 — Continuing with known gaps

### Problem / objective

Snapshot 4's coherence run left six unresolved gaps. Phase 1 could not wait for information the business does not currently track.

### Decision / work

On 21 September at 15:25 UTC the Product Owner took `CONTINUE_WITH_GAPS` exactly once through the application, moving `GAP_RESOLUTION_REQUIRED → PHASE1_READY` (workflow v18). The transition records Snapshot 4, the coherence run and the prompt version.

### Result

Six gaps carried forward into Phase 1 — four High (financial performance; sales and conversion; marketing and acquisition; revenue mix) and two Medium (customers and market; delivery and capacity).

**`CONTINUE_WITH_GAPS` did not resolve the gaps.** They remain open on record and enter every later stage as limitations.

### Why it mattered

The system can proceed under acknowledged ignorance without pretending the ignorance is gone. Missing data never becomes evidence of poor performance.

### Relevant records

- [`docs/current-status.md`](../current-status.md) — the six gaps, listed in full

---

## 21–22 September 2026 — Milestone 4: the Phase 1 Diagnosis contract

### Problem / objective

Diagnosis is where a model's interpretation could most easily be mistaken for fact. The contract had to make that impossible by construction.

### Decision / work

M4-05, M4-06 and M4-07 defined and implemented the diagnosis contract (PR #13, `ca63e4f`; migration `0007_phase1_diagnosis`, additive, applied to live after approval). The pieces that matter:

- **Deterministic calculations** are computed by software, not the model, and are exposed as derived values with their formula, rule version and precision.
- **The evidence/interpretation boundary** is enforced: an item declares its grounding (`evidence_backed`, `calculated`, `interpretive`, `hypothesis`) and must cite primary support appropriate to it, or state its limitation.
- **Grounding and reference handling** uses snapshot-local handles; every citation is resolved and validated against the run's own reference map, and a validated gap may only be cited as a limiting gap.
- **Workflow preconditions** are enforced transactionally, so a state change cannot outrun the artifact it depends on (M4-04).
- **The run and its artifact are immutable**, with the approved artifact built server-side from locked rows.
- **Human review** decides every item, and **approval** is a separate, explicit act.

Two refinements landed during the same period: an all-rejected diagnosis cannot be approved (`7d6a540`), and a revised diagnosis requires a newer snapshot rather than a re-run of the same one (`183c41b`).

M4-13 then closed the last gap before approval: the review page must show the **effective** item — exactly what approval will persist, including corrections — so a reviewer approves what they can see (PR #18, `23750b4`).

M4-03 was dispositioned as **open but non-blocking** for Snapshot 4 under a no-`v7` guardrail, rather than being marked resolved.

### Result

A diagnosis contract in which AI analyses one immutable snapshot, software enforces the rules, and a human approves the interpretation.

### Relevant records

- Decision: [`docs/baslon-os-m4-05-m4-06-m4-07-phase1-diagnosis-contract-architecture-decision.md`](../baslon-os-m4-05-m4-06-m4-07-phase1-diagnosis-contract-architecture-decision.md)
- Implementation: [`docs/milestone-4-m4-05-06-07-phase1-diagnosis-contract.md`](../milestone-4-m4-05-06-07-phase1-diagnosis-contract.md)
- PRs #13 (`ca63e4f`), #15 (`7c498b3`), #16 (`f6be11c`), #17 (`d40a794`), #18 (`23750b4`), #19 (`ca36489`)

---

## 22 September 2026 — The first live Phase 1 Diagnosis

### Problem / objective

Run the contract, once, on real evidence.

### Decision / work

Diagnosis run **`1a03e409-0f2e-4bb7-9de9-01be66c0f84f`** analysed **Snapshot 4** under `phase1_diagnosis_input_v1` / `phase1_diagnosis_v1`, and produced **14 diagnosis items**. It succeeded on the first attempt, and the workflow stopped at the human review checkpoint rather than advancing on its own.

Human review recorded **10 ACCEPTED, 4 CORRECTED, 0 REJECTED**. The four corrections (I001, I002, I006, I014) tightened wording and references rather than changing the analysis: one preserved a positioning statement as positioning rather than fact, one removed an evaluative word while keeping the documented figure, one removed a duplicate claim reference, and one framed an item explicitly as a strategic decision.

### Result

A reviewed diagnosis, still analytical state. A diagnosis item is not canonical evidence and never becomes a Claim.

### Why it mattered

It proved the whole chain end to end on real data: snapshot → analysis → deterministic calculation → human review, with canonical records untouched throughout.

### Relevant records

- [`docs/current-status.md`](../current-status.md) — the "Phase 1: APPROVED" record and the ten validated properties of the first cycle

---

## 22 September 2026 — Phase 1 approval

### Problem / objective

Turn a reviewed diagnosis into an explicit, auditable basis for the next strategic phase — without overstating what that means.

### Decision / work

The Product Owner approved the diagnosis. The server built the artifact from locked, persisted rows; the review session moved `OPEN → COMPLETED`; one `APPROVE_PHASE1` transition moved the workflow `PHASE1_AWAITING_REVIEW → PHASE1_APPROVED` (v20 → v21).

```text
Approved diagnosis   a4e4f0e0-3544-4650-95ee-f13d31b36517  (version 1)
Artifact contract    phase1_diagnosis_artifact_v1
Approved content     md5 0f9fe3b044a49bc626891edea44f08fe
Workflow             PHASE1_APPROVED v21
```

### Result

All 14 approved items matched the effective pre-approval reviewed values field for field, and canonical Claims, Evidence, Metrics and relationships were unchanged.

### What approval does and does not mean

Approval accepts the reviewed diagnosis as the current analytical basis for the next phase. It does **not**:

- make any Claim true;
- resolve any evidence gap — the six gaps remain unresolved;
- convert a deterministic calculation into a realised figure — they remain derived run-rates;
- turn AI interpretation into canonical evidence;
- validate the diagnosis conclusions as objective truth.

### Relevant records

- PR #20 (`5910d5e`) recorded the approval and the Phase 2 entry boundary
- [`docs/current-status.md`](../current-status.md)

---

## 22 September 2026 — Diagnosis information architecture

### Problem / objective

The approved diagnosis was correct but read like a database view. A consultant or business owner needed to be able to scan it.

### Decision / work

PR #21 (`32996a6`) first gated the approved presentation on workflow state, so the approved view cannot appear unless the workflow and the artifact agree; any mismatch fails closed with an integrity notice.

PR #23 then redesigned the approved diagnosis into five views:

```text
Overview            business meaning first
Full Diagnosis      all 14 approved items
Evidence Gaps       the six unresolved gaps
Calculations        the six deterministic calculations
Audit & Provenance  identifiers, hashes, and the original AI proposals for corrected items
```

Progressive disclosure keeps reasoning and evidence one click away rather than on the surface.

### Result

Merged as **`45ed2f839ee48955fabd627aa027f00a2c6901e7`**, verified afterwards against the live approved diagnosis with no data change.

### Why it mattered

It moved the product from "correct but unreadable" toward a consultant-readable surface, without altering a single approved value.

### Relevant records

- PRs #21 (`32996a6`), #22 (`c412f41`), #23 (`45ed2f8`)

---

## 22–23 September 2026 — The diagnosis headline extension

### Problem / objective

Even redesigned, the Overview led with full approved statements — accurate, but slow to scan. A short label per item would help, but inventing labels at render time would put unreviewed model text in front of a user, and rewriting the approved statements was out of the question.

### Decision / work

Headlines were introduced as **reviewed presentation labels**, under one rule:

> The approved diagnosis statement remains the substantive analytical authority. The headline is a human-reviewed presentation label.

Two paths were built (PR #24, `32f5529`):

- **Future diagnoses** carry native headlines through `phase1_diagnosis_v2` and `phase1_diagnosis_artifact_v2`, with version dispatch on the run's recorded prompt version so v1 behaviour is untouched.
- **The existing approved v1 diagnosis** is labelled by a separate, immutable **companion headline set**, bound to that exact approved diagnosis, version and run. `approved_diagnoses.approved_content` was never modified.

Migration `0008_diagnosis_headlines` (additive; nullable column, no backfill) was applied to live on 22 September. Before it, a verified production backup was taken (see below). The pre-merge application was then rebuilt and checked against the migrated schema to prove old code tolerates the new schema.

Generation, review and approval ran as three separately authorised steps:

```text
Proposal run     d97b01b7-d41c-4312-a9b9-2b9186ad4da6   14 proposals, validated, fail-closed
Review session   33622bdf-e530-45c4-ab8b-eb902abc23f9   10 ACCEPTED, 4 CORRECTED
Headline set     b586678b-3871-4939-9446-de84fceddba5   version 1, approved by David Demetrius
```

The model saw only each item's handle, type and approved statement — no canonical Claim, Evidence, Metric or identifier. Deterministic validation rejected any headline that was blank, over 120 characters, multi-line, punctuation-only, duplicated, or that introduced a number its statement did not contain.

### Result

The Overview now leads with reviewed headlines and keeps each approved statement directly beneath. Full Diagnosis shows all 14 headlines above their statements with review status intact; Audit & Provenance records the headline set's identity, version, approver and binding. Headline approval created **no workflow transition** — the workflow is still `PHASE1_APPROVED` v21.

### Why it mattered

A scannable surface was added without giving presentation any authority over analysis, and without touching an approved artifact.

### Relevant records

- [`docs/milestone-4-diagnosis-item-headline-extension.md`](../milestone-4-diagnosis-item-headline-extension.md) — the design and the full list of the 14 approved headlines
- PR #24 (`32f5529`)

---

## 22–23 September 2026 — Operational baseline: backups and restore

### Problem / objective

Applying migration `0008` to live exposed an operational gap: there was no established backup or restore procedure, and no verified restore point.

### Decision / work

A minimum backup and restore runbook was written, and a restore point was actually proved: a full logical backup of live `baslon_os` at migration baseline 9 was taken, checksummed, structurally inspected and **restored into a disposable database**, whose fingerprint matched production exactly before it was dropped. The backup is held outside the repository and is never committed.

### Result

**P-13 is resolved at the minimum operational baseline** (PR #25, `0624c74`). Deliberately still open: scheduled backups, offsite or encrypted storage, incident handling, and a formal migration rollback / forward-fix policy.

### Why it mattered

It is the first time recoverability was a tested property rather than an assumption — and the gap was recorded honestly rather than closed off in full.

### Relevant records

- [`docs/operations/postgres-backup-restore-runbook.md`](../operations/postgres-backup-restore-runbook.md)
- [Findings register, P-13](../baslon-os-consolidated-code-review-findings-register.md)
- PR #25 (`0624c74`)

---

## 23 September 2026 — Phase 1 closure

### Problem / objective

Record the completed state in the repository so it survives outside any conversation.

### Decision / work

The status and milestone documentation were updated to the verified live state and merged as **`c5e9c4c267c14ca96f1849ceed17aa704c681f8c`** (PR #26).

### Result — the current historical endpoint

```text
Phase 1 Diagnosis      COMPLETE AND APPROVED   (approved diagnosis a4e4f0e0-…, PHASE1_APPROVED v21)
Diagnosis IA           COMPLETE                (five views, PR #23)
Headline extension     COMPLETE AND LIVE       (PR #24, migration 0008 applied)
Headline set           VERSION 1 APPROVED      (b586678b-…, 10 accepted / 4 corrected)
Operational baseline   P-13 minimum baseline   (verified restore point; wider hardening open)
Phase 2                NOT STARTED
```

Open work remains open: M4-03, B-09, B-19, B-31, B-32, B-33 and the production hardening beyond P-13 are unchanged by this closure. Phase 1 being complete does not make the project defect-free.

### Relevant records

- [`docs/current-status.md`](../current-status.md)
- [`milestones.md`](milestones.md), [`decision-log.md`](decision-log.md)
- PR #26 (`c5e9c4c`)

---

## What happens next

Nothing in this repository describes Phase 2 as started, planned in detail, or authorised. `docs/current-status.md` records only the **entry boundary**: Phase 1 must be `PHASE1_APPROVED`; the approved artifact is the analytical authority; gaps stay gaps; calculations stay derived; provenance must be carried; and material strategic choices still require human checkpoints. The next milestone action is for the Solution Architect and Product Owner to define.
